OR WAIT null SECS
September 04, 2019
Vertex will use the acquisition to develop cell-based treatments for type 1 diabetes.
September 03, 2019
Valo Therapeutics has acquired a technology from Helsinki University that is expected to broaden its approach and expand the capability of its cancer vaccines platform, PeptiCRAd.
The new facility, located in Ness Ziona, Israel, will support clinical phage manufacturing and can be expanded in the future to support commercial-scale manufacturing.
The partnership will provide cost effective biologics for the world market.
A global agreement with Polpharma Biologics gives Sandoz commercialization rights to a proposed biosimilar natalizumab for relapsing-remitting multiple sclerosis.
September 02, 2019
In this interview, the main uses and benefits of NIR spectroscopy in tableting are discussed.
The authors provide an introduction to aluminum adsorbed vaccines, review studies of antigen stability, and propose test methods for the analysis of aluminum vaccine release and stability analysis.
Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies.
Research compared the properties of corticosteroids processed by wet and dry milling for use in inhalation formulations.
September 01, 2019
The evolution of cell-culture technology is driving the need for improvements in modeling solutions.